Get the Stockscreener App
1.82
5.89%
-0.114
After Hours:
1.75
-0.07
-3.85%
China Pharma Holdings Inc. stock is traded at $1.82, with a volume of 29,284.
It is down -5.89% in the last 24 hours and down -0.55% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.934
Open:
$1.97
24h Volume:
29,284
Relative Volume:
0.47
Market Cap:
$5.94M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-5.4167
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
-3.70%
1M Performance:
-0.55%
6M Performance:
+33.33%
1Y Performance:
-22.55%
1-Day Range:
$1.80
$1.9978
1-Week Range:
$1.80
$2.00
52-Week Range:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.82 | 6.31M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
Is China Pharma Holdings Inc. (XQJ0) stock attractive for growth fundsTrade Volume Summary & Safe Capital Investment Plans - newser.com
How to recover losses in China Pharma Holdings Inc. stockAnalyst Upgrade & Weekly Watchlist of Top Performers - newser.com
Why analysts raise outlook for China Pharma Holdings Inc. stockMarket Movement Recap & Technical Entry and Exit Tips - newser.com
Is China Pharma Holdings Inc. (XQJ0) stock in buy zone after pullbackTrade Entry Report & Verified Swing Trading Watchlist - newser.com
Has LakeShore Biopharma Co. Ltd Equity Warrant found a price floorGDP Growth & Weekly Top Gainers Trade List - newser.com
Has China Pharma Holdings Inc. found a price floorTrade Risk Summary & Weekly High Return Stock Opportunities - newser.com
Visual trend scoring systems applied to China Pharma Holdings Inc.Earnings Risk Report & Precise Trade Entry Recommendations - newser.com
Will China Pharma Holdings Inc. stock benefit from commodity supercycleJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
What drives China Pharma Holdings Inc stock priceDividend Stability Analysis & Free Tremendous Growth Opportunities - earlytimes.in
MindHYVE.ai™ Partners with the Government of Pakistan to Support Implementation of the National AI Policy 2025 - digitalmore.co
Will Product Innovation Drive Esaar India Limited Stock in YEARPrice Support Zones & Affordable Growth Trading - earlytimes.in
Why Hedge Funds Are Buying The Orissa Minerals Development Company Limited in YEARMarket Correction Analysis & Advanced Stock Screening Tools - earlytimes.in
Can Zuari Industries Limited Deliver Margin Expansion Amid InflationPrice Support Zones & Get Trading Help From Experienced Users - earlytimes.in
Is China Pharma Holdings Inc. forming a reversal pattern2025 Risk Factors & Low Risk High Reward Ideas - newser.com
Will China Pharma Holdings Inc. stock return to pre crisis levels2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com
Backtesting results for China Pharma Holdings Inc. trading strategiesJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - newser.com
Is China Pharma Holdings Inc. (XQJ0) stock safe for risk averse investorsJuly 2025 Price Swings & AI Powered Market Trend Analysis - newser.com
Risk adjusted return profile for China Pharma Holdings Inc. analyzedJuly 2025 PreEarnings & AI Enhanced Trading Alerts - newser.com
Risk vs reward if holding onto China Pharma Holdings Inc.2025 Earnings Surprises & High Return Stock Watch Alerts - newser.com
Is Sikozy Realtors Limited a Safe Haven Stock During Market StressPortfolio Risk Assessment & Free Transform Portfolio With Stocks - earlytimes.in
Is China Pharma Holdings Inc. stock cheap by valuation metricsJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - newser.com
Can machine learning forecast China Pharma Holdings Inc. recovery2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Will China Pharma Holdings Inc. (XQJ0) stock sustain bullish trend into 2025Earnings Performance Report & Risk Managed Trade Strategies - newser.com
How moving averages guide China Pharma Holdings Inc. tradingRecession Risk & Fast Entry Momentum Trade Alerts - newser.com
Can Bhagawati Oxygen Limited Deliver on Promised Growth AmbitionsMarket Sentiment Extremes & Watch Expert Picks Before They Rally - earlytimes.in
Can Vinyl Chemicals India Limited Deliver Double Digit Returns in the Next YearMonthly Performance Summary & Get Ahead with Our Profit-Packed Picks - earlytimes.in
Is the Market Underestimating Patidar Buildcon Limiteds PotentialStock Price Forecasts & Big Profit Low Capital - earlytimes.in
What analysts say about POET Technologies Inc stockGap Up/Gap Down Analysis & Budget Friendly Trading Strategies - earlytimes.in
Will China Pharma Holdings Inc. stock sustain dividend payoutsJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - newser.com
Is IDream Film Infrastructure Company Limited a Smart Pick for Retirement PortfoliosSwing Trading Watchlist & Rapid Capital Portfolio - earlytimes.in
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):